AbbVie signs $225m ‘immunoneurology’ deal to tackle Alzheimer’sPartnership will use novel approach to treating Alzheimer’s. Share XAbbVie signs $225m ‘immunoneurology’ deal to tackle Alzheimer’shttps://pharmaphorum.com/news/abbvie-immunoneurology-alzheimers/